We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STN:NYSEStantec Inc Analysis

Data as of 2026-08-02 - not real-time

$70.49

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Stantec Inc. (STN) is trading at $70.49, well below its DCF-derived fair value of $102.43, suggesting a sizable discount. The stock’s trailing P/E of 23 is comfortably under the industry average of 31, while the forward P/E of 14.4 signals improving earnings expectations. Revenue is expanding at a solid 9% YoY with a healthy gross margin of 54% and operating margin above 10%, underscoring robust operational performance. Cash flow remains strong, with operating cash flow of $760 M and free cash flow of $739 M, supporting the modest 21% payout ratio and a dividend yield near 1%. However, the balance sheet carries a net debt of $2.23 B (debt‑to‑equity 77%), which warrants monitoring. Technicals show a mixed picture: price sits above the 20‑day SMA but below the 50‑day SMA, the MACD histogram is positive and the signal line is bullish, yet the 30‑day volatility is high at ~30% and the long‑term trend remains bearish. Recent news highlights a strategic joint‑venture win in Melbourne’s water infrastructure and a forthcoming Q2 earnings release, both of which could catalyze short‑term upside. Investor sentiment is buoyant, reflected by an “Extreme Greed” reading of 92.9 on the Fear & Greed Index. Overall, the combination of valuation discount, solid fundamentals, and positive project pipeline positions STN as an attractive entry point, provided investors are comfortable with the inherent cyclical and leverage risks.
While the stock’s upside potential appears compelling, the elevated volatility and debt levels suggest a measured approach, with a focus on upcoming earnings and cash‑flow trends to confirm the upside narrative.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term support and mixed technical signals
  • Upcoming Q2 earnings could clarify momentum
  • High 30‑day volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation discount to DCF fair value
  • Strong cash flow supporting dividend and debt service
  • Strategic project win in Australia expanding growth pipeline

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustained revenue growth and improving margins
  • Undervalued relative to industry peers with attractive forward P/E
  • Continued dividend sustainability and solid ROE

Key Metrics & Analysis

Financial Health

Revenue Growth9.10%
Profit Margin7.39%
P/E Ratio23.0
ROE15.28%
ROA6.63%
Debt/Equity76.67
P/B Ratio3.4
Op. Cash Flow$759.9M
Free Cash Flow$739.2M
Industry P/E30.9

Technical Analysis

TrendBearish
RSI51.4
Support$66.26
Resistance$72.33
MA 20$69.34
MA 50$71.08
MA 200$89.28
MACDBullish
VolumeStable
Fear & Greed Index92.88

Valuation

Fair Value$102.43
GradeUndervalued
TypeBlend
Dividend Yield0.95%

Risk Assessment

Beta0.82
Volatility29.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.